Wojewodzki Szpital Specjalistyczny Im. Sw. Rafala W Czerwonej Gorze — Clinical Trial Site

10 Registered trials

5 Currently recruiting

Organisation

Wojewodzki Szpital Specjalistyczny Im. Sw. Rafala W Czerwonej Gorze

Location

Checiny, Poland

Identifier

ORG-100048680

Address

Ul. Jagiellonska 72, 25-734, Poland

Departments

Oddzial IV Alergologiczny
Oddział IV Alergologiczny
Wojewodzka Przychodnia Specjalistyczna Szpitala w Czerwonej Gorze Poradnia Alergologiczna
Wojewodzki Szpital Specjalistyczny Im. Św. Rafała w Czerwonej Górze

Clinical trials at this site (10)

Search interface

A randomized, double-blind, placebo-controlled clinical endpoint bioequivalence study to evaluate the therapeutic equivalence and safety of … Not authorised

2025-521565-27-00 Asthma 5
Long-term safety and efficacy evaluation of lunsekimig (SAR443765) in adult participants with moderate-to-severe asthma. Recruiting

2025-522896-27-00 Asthma 4 2026-05-11
A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease Recruiting

2025-520473-40-00 Moderate to Very Severe Chronic Obstructive Pulmonary D 4 2025-09-29
Study of lunsekimig (SAR443765) compared with placebo in adults with high-risk asthma Recruiting

2024-513959-33-00 Asthma 4 2025-05-13
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
A study to Investigate the efficacy and safety of Depemokimab compared with placebo in Adults with Hypereosinophilic Syndrome (HES) Recruiting

2023-510346-25-00 Hypereosinophilic Syndrome (HES) 5 2022-09-01
A study to evaluate if benralizumab may be beneficial in the treatment of Hypereosinophilic Syndrome (HES). Ended

2023-510455-28-00 Hypereosinophilic Syndrome (HES) 5 2020-06-10
A study to investigate the effect on lung function of an approved COPD treatment (BGF, with HFA propellant) compared to BGF formulated with… Ended

2023-506565-57-00 Moderate to Severe Chronic Obstructive Pulmonary Diseas 5 2024-06-21
"A Variable Length Study to Evaluate the Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol inhaler in Adults and Adolescents with … Ended

2023-505787-11-00 Severe and inadequately controlled asthma 5 2021-04-29
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with a History of Frequent Exace… Ended

2022-503050-39-00 Moderate to Very Severe Chronic Obstructive Pulmonary D 5 2019-11-12